Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 60760-819

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 60760-819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem Tartrate (8bb9d44d 6ee5 4174 8d42 52078de66779 01)

Chemical structure of Zolpidem Tartrate, illustrating the molecular composition including aromatic rings and functional groups defining the compound's chemical identity.*

FDA Label Image

Im-2 (8bb9d44d 6ee5 4174 8d42 52078de66779 02)

A pharmacokinetic plasma concentration-time curve comparing zolpidem plasma concentrations (ng/mL) over 8 hours between 12.5 mg zolpidem tartrate extended-release tablets and 10 mg zolpidem tartrate immediate-release tablets, showing concentration peaks and decline over time.*

FDA Label Image

819- (Zolpidem 60760 819 30)

Label for Zolpidem Tartrate Extended-Release Tablets USP 12.5 mg, quantity 30. The label shows the product name, dosage strength, and extended-release tablet form. It includes the NDC 60760-819-30 and barcodes. The product is manufactured by Lupin Limited, Goa, India, and packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. The label indicates storage instructions for controlled room temperature 15°-30°C and includes usage direction 'Use as directed.' Lot number and expiration date are marked with question marks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.